The UCD Irish Institute for Chinese Studies (IICS) held a public lecture and the 50th Confucius PhD Student Forum on 9 February 2023. The keynote lecture was delivered by Professor Sanbing Shen from the Regenerative Medicine Institute (REMEDI) at the School of Medicine, University of Galway (UOG). The forum was held simultaneously via hybrid methods, where nearly 100 people attended. The lecture was opened by Liming Wang, Director at UCD Confucius Institute and Irish Institute for Chinese Studies.
With the theme of "Human Stem Cells and Genome Editing for Chinese Medicine", Professor Sanbing Shen used the knowledge of traditional Chinese medicine as a starting point to talk about the reasons and motivations that inspired him to carry out the relevant research, and to explain in depth the prospects of how the combination of Chinese medicine and stem cell research can treat human diseases.
According to Professor Shen, Chinese medicine has been benefiting the Chinese people for over 5000 years, and research into the identification and purification of its effective ingredients is an important complement to western medical systems. Today, human stem cell and gene editing studies provide a unique opportunity for developing Chinese medicine, while libraries of small molecules are yet to be constructed from Chinese herbs. It is believed that international collaborative research shall help further development of Chinese medicine and the development of combinatorial therapy of Chinese and regenerative medicine will benefit the global human kind.
The presentation was followed by a lively discussion with the audience on the specific utility of the research as applied to genetic diseases such as diabetes, and its effective treatment mechanisms.
Watch (opens in a new window)here
爱尔兰中国研究院举办公共讲座暨第50届孔子博士论坛
2023年2月9日，都柏林大学中国研究院举办了公共讲座暨第50届孔子博士生论坛。爱尔兰国立高威大学（University of Galway）医学院（School of Medicine）再生医学研究所（REMEDI）沈三兵教授做了主题演讲。论坛以线上和线下相结合的方式同时进行，讲座由都柏林大学爱尔兰中国研究院院长王黎明致开场辞，现场有近百人参加了本次论坛。
沈三兵教授以“用于中药的人类干细胞和基因组编辑”为主题，以传统中医知识为切入点，讲述了激励自己进行相关研究的起因与动力，并深入浅出地讲解了中药与干细胞研究的结合如何治疗人类疾病的前景。
沈教授认为，中医造福中国人已超过 5000 年，而其中有效成分的鉴定和纯化研究是对西方医学体系的一个重要补充。如今，人类干细胞和基因编辑研究为发展中药提供了一个难得的机会，而中草药的小分子库尚待构建。相信国际合作研究将助力中医药的进一步发展，中医药与再生医学联合疗法的发展将造福全球人类。
演讲结束后，观众还就该研究应用于糖尿病等遗传病的具体效用，及其有效的治疗机制展开了热烈讨论。